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Purpose: To establish the immortalized human corneal endothelial cell line (IHCEn) by transducing human 
papilloma virus (HPV) 16 E6/E7 oncogenes, and to identify their characteristics when cultivated on a 
lyophilized human amniotic membrane (LAM).
Methods: Primary human corneal endothelial cells (PHCEn) were infected using a retroviral vector with HPV 
16 E6/E7, and transformed cells were clonally selected by G418. Growth properties and characteristics of 
IHCEn were compared with PHCEn by cell counting and RT-PCR of VDAC3, SLC4A4, CLCN3, FGF-1, Col 
Ⅳ, and Na
+/K
+ ATPase. IHCEn were cultured on LAM. Messenger RNA expressions of VDAC3, CLCN3, and 
Na
+/K
+ ATPase, and protein expressions of Na
+/K
+ ATPase and Col Ⅳ in IHCEn cultivated on LAM were 
investigated by RT-PCR, immunofluorescence, and immunohistochemical staining, respectively.
Results: Successful immortalization was confirmed by stable expression of HPV 16 E6/E7 mRNA by 
RT-PCR, and IHCEn exhibited typical corneal endothelial morphology. Doubling time of IHCEn was 30.15±
10.96 hrs. Both IHCEn and PHCEn expressed VDAC3, CLCN3, SLC4A4, FGF-1, Col IV, and Na
+/K
+ 
ATPase. IHCEn cultivated on LAM showed stronger expression of VDAC3, CLCN4, and Na
+/K
+ ATPase 
mRNA than on plastic culture dish. Immunohistochemical staining and immunofluorescence revealed the 
positive expression of Na
+/K
+ ATPase and Col IV.
Conclusions: IHCEn were successfully established, and LAM is a good substrate for the culture of human 
corneal endothelial cells.  Korean Journal of Ophthalmology 20(1):47-54, 2006
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The corneal endothelium, a monolayer of differentiated 
cells located in the posterior portion of the cornea, is essential 
for maintaining corneal transparency by their dehydrating 
pumping action on the corneal stroma, and at least 1,500 
corneal endotheial cells/mm
2 are required for normal corneal 
function. The human corneal endothelium comprises a 
postnatal density of approx. 3,000 cells/mm.
1,2 During life we 
experience a physiological reduction of cell density of about 
0.5% per year,
3 and endothelial cell loss can increase after 
intraocular surgery or in certain inherited diseases.
4,5 
Although once the density of endothelial cells, which have 
a limited regenerative capcity, reaches a critically low 
number, the integrity of the monolayer can be compromised, 
resulting in stromal edema, corneal opacity, and loss of visual 
acuity.
6 
Since a minimum cell density of 500 cells/mm
2 is necessary 
to ensure a proper pump function, the only effective therapy 
to restore the corneal endothelium and thereby vision is 
corneal transplantation. Nevertheless, successful corneal 
transplantation also requires an optimum endothelial cell 
density, and donated corneas are very limited in Korea. To 
overcome these limitations, culturing human corneal 
endothelial cells on suitable biomaterials and transplanting 
the construct containing the intact endothelial monolayer to 
the posterior of the cornea was attempted.
7-16 However, these 
experiments were limited by several problems: a lack of cell 
adherence after transplantation with insufficient substances, Kor  J  Ophthalmol  Vol.20,  No.1,  2006
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the use of non-human corneas, and insurance of a sufficient 
number of corneal endothelial cells.
Recently, the culture of corneal endothelial cells on 
biodegradable membranes
17 and human corneal endothelium 
used for transplantation were genetically manipulated by 
transfection with the SV40 large T-antigen.
18 One group also 
pursued an alternative strategy to increase the endothelial cell 
density by transplanting cultured corneal endothelial cells 
onto donor corneas, which were unsuitable for transplan-
tation.
19 Although these experiments reported a 80-90% graft 
success rate, the use of donated human cornea has a low 
efficiency and did not overcome the limitation of corneal 
transplantation. Therefore, two questions must be resolved for 
corneal endothelial cell transplantation.
First, the isolation of sufficient human corneal endothelial 
cells is essential for corneal endothelial cell transplantation. 
The most widely used method for immortalization of cells is 
the viral oncogene, SV40 large T-antigen, and immortali-
zations of corneal endothelial cells have been reported using 
human and murine cells.
20,21 However, such cell lines had 
been shown to exhibit abnormal phenotypes, including a 
reduction of Na
+/K
+ pumping action and alterations of 
collagen expression. Recently, the establishment of more 
stable and physiologically relevant cell lines has been 
reported by transducing human papilloma virus (HPV) type 
16 E6/E7 genes into various primary cells.
2,3,5 E6 proteins are 
approximately 150 amino acids in length, and have the 
important function of binding the tumor suppressor p53, 
which results in its ubiquitin-mediated degradation.
22 E7 
proteins are approximately 100 amino acids in length, and 
associate with a member of the retinoblastoma tumor 
suppressor family to facilitate progression into S phase.
23 
Moreover, the E7 protein provides the synergistical trans-
forming activity together with the E6 protein.
24,25 Therefore, 
a more stable immortalization was expected by transducing 
with E6 and E7 in human corneal endothelial cells.
The second necessity for corneal endothelial cell transplan-
tation is the development of a proper substrate sufficient not 
only for the corneal endothelial cells to adhere and grow, but 
also to transplant. As mentioned above, previously attempted 
substrates were abnormal corneal or biochemical materials. 
These substrates were not appropriate for the culture and 
transplantation of corneal endothelial cells, in addition to 
being very expensive and inefficient.
Human amniotic membrane, the innermost layer of human 
placenta, is harmless to humans and stimulates no immune 
reactions. The amniotic membrane also promotes wound 
healing and has a cell-protecting effect, which results in its 
clinical use in dermatology and ophthalmology for dressing 
wounds. Furthermore, the amniotic membrane has similar 
aspects to Descement's membrane. The major components of 
basement membrane are type IV, V, and VII collagen, and 
abundant extracellular matrix proteins including laminin and 
integrin. The use of amniotic membrane as a substrate and 
scaffold for the culture of corneal endothelial cells was 
expected to be successful.
Therefore, this experiment was conducted to establish 
immortalized human corneal endothelial cells (IHCEn) by 
stable introduction of HPV 16 E6/E7, and to investigate the 
biological characteristics of an established corneal endothelial 
cell line cultivated on a lyophilized human amniotic 
membrane.
Materials and Methods
1. Materials
All materials for cell culture including fetal bovine serum 
(FBS) and Opti-MEM were obtained from Gibco BRL 
(Grand Island, NY, USA). Other media supplements, such as 
epidermal growth factor (EGF), ascorbic acid, RPMI 1640 
vitamin mixture, insect lipid, and chondroitin sulfate, were 
purchased from Sigma Chemical (St. Louis, MO, USA). 
Nerve growth factor (NGF) was obtained from R&D Systems 
(Minneapolis, MN, USA).
2. Isolation and primary culture of corneal 
endothelial cells
Human eyes were obtained in accordance with the tenets 
of the Declaration of Helsinki and proper informed consent. 
Human corneal endothelial cells were isolated by trypsin 
digestion of the posterior portions of excised cornea. After 
enzymatic digestion at 37℃ for 10 to 15 min, the endothelium 
was removed by gentle scraping, and seeded onto a tissue 
culture dish in Opti-MEM supplemented with 5 ng/ml of 
EGF, 20 ng/ml of NGF, 20 µg/ml of ascorbic acid, 0.005% 
insect lipid, 200 mg/l of CaCl2, 0.02% chondroitin sulfate, 
1% RPMI 1640 vitamin mixture, and 8% FBS.
3. Retroviral infection of primary corneal 
endothelial cells
PA317 amphotropic packaging cell lines stably transfected 
with pLXSN 16 E6-E7 (HPV 16 E6/E7) were purchased 
from American Type Culture Collection (ATCC, Manassas, 
VA, USA). Cells were grown to 70-80% confluence, and 
supernatants were collected for 24 hr and stored in aliquots 
at -80℃. The primary endothelial cells were infected with 1 
ml of virus stock in 3 ml of medium containing Polybrene 
(Sigma, MO, USA) at 4 µl/ml for 24 hr. The virus was then 
removed and the medium replaced by Opti-MEM supple-
mented with 8% FBS and other supplements as described 
above. Selection media with 200 µg/ml G418 (DUCHEFA, 
Amsterdam, Netherlands) was added after 72 hr. Cultures 
were maintained in selective media for two to three weeks. 
The G418-selected transformed cells were then grown and 
expanded further.HJ  Kim,  et  al.  ESTABLISHMENT  AND  CHARACTERIZATION  OF  IHCEn
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Name Sequence Size  (bp)
Collagen  type  Ⅳ F:  5'-GGC  ACC  TGC  CAC  TAC  TAC  GC-3'
R:  5'-TCA  CCA  GGA  GGT  AGC  CGA  T-3'
472
keratin  12 F:  5'-GAT  GCT  AAT  GCT  GAG  CTC  GA-3'
R:  5'-ACC  TGC  CCT  ACA  GCT  TTG  TA-3'
393
HPV  E6 F:  5'-GCA  ATG  TTT  CAG  GAC  CCA  CA-3'
R:  5'-CAG  GAC  ACA  GTG  GCT  TTT  GA-3
340
HPV  E7 F:  5'-TGG  AGA  TAC  ACC  TAC  ATT  GC-3'
R:  5'-GTG  TGC  CCA  TTA  ACA  GGT  CT-3'
254
VDAC3
a F:  5'-TGA  CTC  TTG  ATA  CCA  TAT  TTG  TAC  CG-3'
R:  5'-GGT  TGT  ACC  ACA  ACG  CAC  TAA-3'
482
CLCN3
b R:  5'-TCA  ATT  TGA  CTC  CTG  GTC  GAA-3'
F:  5'-AGA  AAG  GCA  TAG  ACG  GAT  CAA-3'
204
SLC4A4
c F:  5'-GTT  CAG  ATG  AAT  GGG  GAT  ACGC
R:  5'-CGA  GCA  TAA  ACA  CAA  AGC  GTA  A-3'
697
TGF-β 2
d F:  5'-AAT  GCC  ATC  CCG  CCC  ACT  TTC  -3'
R:  5'  -TCC  CAG  GTT  CCT  GTC  TTT  ATG  -3'
312
FGF-1
e F:  5'-CGA  CGG  GCT  TTT  ATA  CGG  C-3'
R:  5'-GAG  TCC  GAG  GA  CCG  CGT  T-3'
163
Na
+/K
+ A T P a s e F:  5'-  CCC  AGG  ACT  CAT  GGT  TTT  TC-3'
R:  5'-  GGA  GCA  AAG  CTG  ACC  TGA  AC  -3'
482
GAPDH F:  5'-CCA  CCC  ATG  GCA  AAT  TCC  ATG  GCA-3'
R:  5'-GGT  GCT  GCT  TGT  TAG  GAG  GTC  AAG-3'
593
aVDAC3:  voltage-dependent  anion  channel  3, 
bCLCN3:  chloride  channel  protein  3, 
cSLC4A4:  sodium  bicarbonate  cotransporter  membrane 
4, 
dTGF-β 2:  transforming  growth  factor  beta  2, 
eFGF-1:  fibroblasts  growth  factor-1.
Table 2. Oligonucleotide  sequences  for  RT-PCR
PHCEn IHCEn
VDAC3
SLC4A4
CLCN3
Col  Ⅳ
TGF-β 1
TGF-β 2
Connexin43
FGF-1
FGF-2
Keratin  12
ZO-1
Na
+/K
+ A T P a s e
+
+
+
+
-
+
+
+
-
-
-
+
+
+
+
+
+
+
+
+
+
-
+
+
P H C E n :  p r i m a r y  h u m a n  c o r n e a l  e n d o t h e l i a l  c e l l s ,  I H C E n :  i m m o r -
talized  human  corneal  endothelial  cell  line
Table 1. Messenger  RNA  expression  profiles  in  PHCEn 
and  IHCEn
4. Cell counting
One of the established cell lines was seeded onto 100 
mm-diameter culture dishes at a density of 5×10
4 cells/dish. 
Every two days for 14 days, cells were detached by 0.05% 
trypsin/0.5 mM ethylenediaminetetraacetic acid (EDTA), and 
counted in a hemocytometer in triplicate. For doubling time 
determination, the formula Tc=0.3T / log (A/A0) was used 
where Tc=doubling time, T=initial time, A=the number of 
cells at time T of proliferation, and A0=the number of cells 
at an initial time point.
5. Culture of IHCEn on lyophilized human 
amniotic membrane
Human amniotic membrane from donated human placenta 
tested by hepatitis or HIV infection was pretreated with 
0.025% trypsin-EDTA to remove amnion cells, followed by 
lyophilization and sterilization using EO gas. Lyophilized 
amniotic membranes (LAM) were installed on a Teflon ring, 
and 1×10
5 cells/support IHCEn were seeded onto the 
amnion side of a denuded LAM. Cells were maintained using 
opti-MEM for six days by changing the growth media every 
two days.
6. RT-PCR
Corneal endothelial origin of the primary and transformed 
cells was confirmed by reverse transcription-polymerase 
chain reaction (RT-PCR). Primary cells and established cell 
lines were cultured as above, and total RNA was extracted 
with Trizol reagent (Gibco BRL, NY, USA). The first strand 
of cDNA was synthesized from two µg of the total RNA in 
a 20 µl reaction mixture containing Superscript II RNase, H 
reverse transcriptase, and oligo (dT)18 primer. Target genes Kor  J  Ophthalmol  Vol.20,  No.1,  2006
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Fig. 1. The  morphological  characteristics  of  isolated  primary  human  corneal  endothelial  cells  (PHCEn)  and  immortalized  human  corneal 
endothelial  cells  (IHCEn).  IHCEn  were  polygonal  to  slightly  elongate  in  shape,  similar  to  PHCEn.
Fig. 2. Messenger  RNA  expressions  of  E6/E7  and  keratin  12  in  PHCEn  and  IHCEn.  Successful  immortalization  was  confirmed  by  stable 
expressions  of  E6/E7  oncogenes  only  in  IHCEn.  Both  PHCEn  and  IHCEn  were  confirmed  as  endothelial  in  origin  by  negative  RT-PCR 
results  for  keratin12.
(Table 2) were then amplified, PCR products were run on a 
preparative 2% agarose gel, and the bands were photo-
graphed.
7. Immunohistochemistry and immunofluorescence
An avidin biotin complex technique was selected for 
staining sectioned specimens (2-4 µm). Paraffin sections were 
deparaffinized in xylene, rehydrated through decreasing 
ethanol concentrations and quenched for endogenous peroxi-
dase. Cryostat sections were placed on gelatinized slides, 
fixed in cold acetone and then rinsed in tris-buffered saline. 
Nonspecific background was eliminated by incubating tissue 
sections with non-immuno serum (Histostatin-plus Kits, 
Reagent A; Zymed Laboratories, CA, USA). Sections were 
then incubated with monoclonal mouse anti-human collagen 
IV (Santa Cruze Biotechnology Inc. CA, USA) and anti- 
human Na
+/K
+ ATPase antibody (Santa Cruze Biotechnology 
Inc. CA, USA) overnight at 4℃, followed by extensive 
washing in 0.05 M tris-buffered saline (pH 7.6) before the 
addition of a biotinylated secondary antibody (reagent B). 
Sections were washed again and incubated for one hour with 
peroxidase-conjugated streptavidin (reagent C). The presence 
of peroxidase was revealed by adding a substrate-chromogen 
(3-amino-9-ethycarbazole) solution (reagent D) for immuno-
histochemistry, and an FITC conjugated rabbit anti-mouse 
IgG for immunofluorescence. Sections were counterstained 
with haematoxylin. All sections were photographed and the 
entire tissue area was examined.
Results
1. Characterization of IHCEn
The morphological characteristics of isolated primary 
human corneal endothelial cells (PHCEn) and IHCEn were 
observed using an inverted microspcope. IHCEn were 
polygonal to slightly elongated in shape, similar to PHCEn, 
but were siginificantly different from dendritic corneal 
fibroblasts and small globular-shaped epithelial cells (Fig. 1). HJ  Kim,  et  al.  ESTABLISHMENT  AND  CHARACTERIZATION  OF  IHCEn
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Fig. 4. Messenger  RNA  expressions  of  several  channel  proteins.  VDAC3  (voltage-dependent  annion  channel  3),  SLC4A4  (sodium 
bicarbonate cotransporter, member 4), CLCN3 (chloride channel protein 3), FGF (fibroblast growth factor)-1, Col Ⅳ  (collagen type Ⅳ), and 
Na
+/K
+ A T P a s e  i n  P H C E n  a n d  I H C E n  w e r e  e x a m i n e d  b y  R T - P C R .  M  d e n o t e s  t h e  1 K b  l a d d e r .  T h e r e  w e r e  n o  d i f f e r e n c e s  i n  e x p r e s s i o n  
pattern  between  PHCEn  and  IHCEn.
Fig. 3. C e l l  g r o w t h  c u r v e  o f  e s t a b l i s h e d  I H C E n .  1 ×10
5 I H C E n  
cells/ml  were  counted  every  two  days  for  14  days.  A  geometrical 
increase in cell number was detected from day seven on. Doubling 
time  of  IHCEn  was  30.15±10.96  hrs.
Stable expression of E6/E7 mRNA was observed in IHCEn, 
but not in PHCEn by RT-PCR analysis. Messenger RNA of 
the corneal epithelial cell marker, keratin 12, was not 
expressed in PHCEn and IHCEn (Fig. 2).
Proliferative characteristics of IHCEn were elucidated by 
cell counting every two days for 14 days. The cell growth 
curve of IHCEn showed typical S-curves: minimal growth for 
the initial seven days, geometrical growth until day 14, and 
decreased cell numbers after 14 days. The estimated cell 
doubling time of IHCEn was 30.15±10.96 hrs (Fig. 3). 
IHCEn showed a more extended life span (over passage 30), 
and more rapid proliferation than PHCEn (data not shown).
Transformed traits, except for the transducing of HPV 16 
E6/E7 oncogenes, were examined by RT-PCR of several 
channel proteins including voltage-dependent annion channel 
3 (CDAC3), sodium bicarbonate cotransporter member 4 
(SLC4A4), chloride channel protein 3 (CLCN3), fibroblast 
growth factor (FGF)-1, type IV collagen (Col IV), and 
Na
+/K
+ ATPase in PHCEn and IHCEn. mRNAs for all of the 
mentioned proteins were expressed in IHCEn, with similar 
expression patterns observed in PHCEn.
2. Characterization of IHCEn cultivated on LAM
In order to elucidate the efficiency of LAM for the human 
corneal endothelial niche, IHCEn were cultured on LAM and 
harvested for characterization. Messenger RNA expressions 
of several channel proteins and Na
+/K
+ ATPase were 
observed in established IHCEn cultivated on LAM. More-
over, their expressions were stronger than in cells grown on 
a plastic culture dish (Fig. 5). Immunohitochemical staining 
of Col IV and immunofluorescence of Na
+/K
+ ATPase in 
IHCEn cultivated on LAM also showed positive expressions 
results similar to RT-PCR (Fig. 6).
Discussion
Although the condition of the corneal endothelium is 
essential for corneal transparency, it is difficult to treat 
endothelial-damging corneal diseases, since the corneal cells 
have a very restricted regenerative capacity. In order to 
overcome these limitations, corneal endothelial cell transplan-
tation had been attempted by several groups, but insurance 
of a sufficient number of endothelial cells and the develop-
ment of appropriate endothelial substrates are still not 
guaranteed. Therefore, this experiment was conducted to Kor  J  Ophthalmol  Vol.20,  No.1,  2006
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Fig. 5. Messenger  RNA  expressions  of  channel  proteins  and  Na+/K+  ATPase  in  established  IHCEn  cultivated  on  a  lyophilized  amniotic 
membrane  (LAM)  and  plastic  culture  dish  (PL),  respectively.  IHCEn  cultivated  on  LAM  showed  slightly  stronger  expressions  of  all  factors.
Fig. 6. Immunohistochemical  staining  of  Col  IV  and  Na
+/K
+ 
ATPase in IHCEn cultivated on LAM. (A) H&E staining, (B) immuno-
histochemical  staining  of  Col  IV,  and  (C)  immunofluorescence  of 
Na
+/K
+  ATPase.  Established  cell  lines  cultivated  on  LAM  showed 
positive  expressions  of  Col  IV  (arrow  head)  and  Na
+/K
+ ( g r e e n ) .
establish immortalized human corneal endothelial cells 
(IHCEn) by stable introduction of HPV 16 E6/E7, and to 
investigate the biological characteristics of an established 
corneal endothelial cell line cultivated on lyophilized human 
amniotic membrane, an ideal coreneal endothelial substrate.
IHCEn stably transfected by PA317 amphotropic packaging 
cell lines with pLXSN 16 E6/E7 showed stable expression 
of E6/E7 mRNA. There was no corneal epithelial cell 
contamination observed by RT-PCR analysis of keratin 12, 
a corneal epithelial cell marker (Fig. 2). IHCEn showed 
morphological similarity with PHCEn, a longer life span 
(over passage 30), and more rapid proliferation than PHCEn 
(data not shown). Moreover, IHCEn showed a typical 
S-shaped growth curve by cell counting. The estimated cell 
doubling time of IHCEn, 30.15±10.96 hrs (Fig. 3), was 
faster than that of a previously established rabbit corneal HJ  Kim,  et  al.  ESTABLISHMENT  AND  CHARACTERIZATION  OF  IHCEn
53
endothelial cell line in our laboratory (51.30±7.3 hrs).
26 
Several immortalization techniques on human corneal endo-
thelial cells by transfection of various oncogenes including 
SV40 large T-antigen or HPV 16 E6/E7 had been previously 
reported,
27,28 but there were no reports elucidating the typical 
cell growth properties such as growth curve or doubling time.
Introduction of E6/E7 oncogenes facilitates the degradation 
of p53 and progression into the S phase synergistically.
29-32 
Moreover, their stability was also confirmed by observing 
which gene was non-carcinogenic when injected into nude 
mice.
33 Therefore, we were able to successfully obtain 
abundant populations of highly proliferative and stably 
immortalized human corneal endothelial cells. Furthermore, it 
was also identified that established IHCEn maintained normal 
corneal endothelial functions similar to PHCEn by confirming 
VDAC3, CLCN3, CLC4A4, and Na
+/K
+ ATPase mRNA 
expressions (Fig. 4).
Corneal transparency is maintained by uniform structure, 
avascularity, and hydration of the stroma. The mechanism 
that maintains corneal hydration has an active component, 
HCO3-, which is transported from the stroma to the aqueous 
humor. A number of different hypotheses have been proposed 
to describe the molecular mechanisms that drive the net 
HCO3
－ flux. Common to these models is the recognition that 
the net HCO3
－ flux is coupled to and energized by a 
basolateral Na
+/K
+ ATPase in the corneal endothelium.
34 The 
tendency to swell is due to the presence in the stromal matrix 
of non-diffusible, negatively charged molecules such as 
glycosaminoglycans. Ion transport across the endothelium is 
thought to involve the active transport of anions from the 
stroma towards the aqueous humor, followed by the mainly 
passive diffusion of cations. The osmotic effect of this 
transendothelial ion transport counters the excess osmotic 
potential of the stroma.
34 At hydration levels outside the 
normal range, the cornea loses its transparency. Thus the 
positive expressions of several channel proteins including 
VDAC3 and Na
+/K
+ ATPase mRNA in IHCEn means that 
stably established IHCEn did not lose their normal endo-
thelial functions, and can maintain them during ex vivo 
expansion.
Essential factors for normal endothelial functions such as 
channel proteins or Na
+/K
+ ATPase were positively expressed 
in cultivation not only on plastic culture dishes, but also on 
LAM. Furthermore, the expression patterns on LAM were 
stronger than that on plastic culture dishes. These results 
suggest that human amniotic membrane can act as the ideal 
endothelial niche for IHCEn and PHCEn.
The amniotic membrane has a specific advantage that 
makes it a good substrate for endothelial cell growth. It is 
a biomaterial different from biochemical substrates such as 
gelatin membrane or coated hydrolens, it increases cell 
adherence by abundant extracellular matrix proteins including 
integrin and lamin, and is easily transplanted since its 
physical properties are similar to Descement's membrane. 
Furthermore, our results demonstrate that amniotic membrane 
acts as a good substrate for the maintenance of corneal 
endothelial functions.
This study indicates that a sufficient immortalized cell line 
having characteristics similar to PHCEn is useful for in vitro 
studies of human corneal endothelial functions. Furthermore, 
it is expected that the culture of corneal endothelial cells on 
an amniotic membrane, an ideal corneal endothelial niche, is 
useful for the basic investigation of not only drug response 
or toxicological evaluation, but also for corneal endothelial 
cell transplantation or the development of reconstructed 
bioartificial cornea.
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